山東路橋(000498.SZ):將積極敦促潤陽置業儘快完成備案和登記工作
格隆匯 11 月 18日丨山東路橋(000498.SZ)公佈,公司於2018年7月30日召開第八屆董事會第二十次會議,審議通過了《關於子公司擬購置房產的議案》,同意子公司山東省路橋集團有限公司向山東潤陽置業有限公司(“潤陽置業”)購買其開發的晶石中心A棟房產(“標的房產”)作為公司辦公場所。
目前,標的房產正在辦理實測繪備案等工作。房管審批部門對備案資料進行核查並提出了現場整改要求,潤陽置業已根據要求對相應物業設施進行了整改,現已重新整理資料並上報。公司將積極敦促潤陽置業儘快完成備案和登記工作,敬請廣大投資者注意投資風險。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.